2020-05-11T15:25:48-05:00 2019-12-31 390859910 BAKER TILLY VIRCHOW KRAUSE LLP 1570 FRUITVILLE PIKE SUITE 400 LANCASTER PA 17601 990 2019-01-01 232740843 ALTERNATIVES RESEARCH AND DEVELOPMENT FOUNDATION ALTE 2158878076 801 OLD YORK ROAD NO 316 JENKINTOWN PA 19046 SUE A LEARY PRESIDENT 2158878076 2020-05-11 1 KERRI N BOGDA CPA P00760402 7177404863 73.101.37.214 2020-05-11 10:56:22 ED P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 F58787FA80410BAE38B710EAF9FCC5760AD3BCDF 2019 2021-01-29 14:40:06Z SUE A LEARY 801 OLD YORK ROAD NO 316 JENKINTOWN PA 19046 2575336 0 X WWW.ARDF-ONLINE.ORG X 1993 PA ARDF PROMOTES AND DEVELOPS ALTERNATIVE SCIENTIFIC SOLUTIONS TO THE PROBLEM OF ANIMAL TESTING. 7 6 1 10 0 0 57870 136042 0 0 905312 794185 0 15549 963182 945776 308540 274340 0 0 44409 51741 0 0 8051 214640 199329 567589 525410 395593 420366 10007851 11841958 1335 6774 10006516 11835184 X THE MISSION OF THE ARDF IS TO FUND AND PROMOTE THE DEVELOPMENT, VALIDATION AND ADOPTION OF NON-ANIMAL METHODS IN BIOMEDICAL RESEARCH, PRODUCT TESTING, AND EDUCATION. 0 0 367417 274340 0 THE 'ANNUAL OPEN' GRANT PROGRAM FUNDED PROJECTS AT U.S. UNIVERSITIES THAT WILL DEVELOP NON-ANIMAL MODELS FOR BIOMEDICAL RESEARCH, INCLUDING 'ON-A-CHIP' SYSTEMS TO STUDY MICROBIOME AND DRUG METABOLISM, CHRONIC LIVER CONDITIONS, AND DEGENERATIVE DISC DISEASEALL USING HUMAN CELLS TO BETTER RECAPITULATE HUMAN DISEASE. ANOTHER GRANT FUNDED A MORE EFFICIENT WAY TO EVALUATE ANTIMICROBIALS THAT ACT ON DRUG-RESISTANT ORGANISMS, AND ANOTHER WILL OPTIMIZE IN VITRO CULTIVATION OF HUMAN NOROVIRUS BY EXAMINING THE ROLE OF THE EXOSOME. A FUNDED PROJECT AT AN ITALIAN UNIVERSITY USES COMPUTER SIMULATION TO DESIGN ANTIBODIES, IN ORDER TO REPLACE ONE OF THE MOST PREVALENT USES OF ANIMALS IN LABS. TAKEN TOGETHER, THESE PROJECTS COULD REPLACE OR REDUCE THE PAIN AND DEATH OF HUNDREDS OF THOUSANDS OF ANIMALS IN SCIENCE.ARDF ALSO SPONSORED SCIENTIFIC MEETINGS AND OTHER EDUCATIONAL EFFORTS TO ACCELERATE UNDERSTANDING AND COLLABORATION ON ALTERNATIVE METHODS. 367417 1 1 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 0 0 1 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 4 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 X 7 6 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 PA MN X X SUE LEARY PRESIDENT 2158878076 801 OLD YORK ROAD NO 316 JENKINTOWN PA 19046 SUE A LEARY PRESIDENT 15.00 35.00 X X 20000 51240 16470 JOSEPH LUDWIG VICE PRESIDENT 1.00 1.00 X X 0 0 0 AARON MCINTYRE TREASURER 1.00 1.00 X X 0 0 0 DENISE COWIE SECRETARY 1.00 1.00 X X 0 0 0 DOUGLAS R BARR SR BOARD MEMBER 0.50 0.50 X 0 0 0 FRANCIS KRAFCHIK BOARD MEMBER 0.50 0.50 X 0 0 0 ROBERT FINN BOARD MEMBER 0.50 0.50 X 0 0 0 20000 51240 16470 0 0 0 0 MORGAN STANLEY 1585 BROADWAY NEW YORK NY 10036 INVESTMENT SERVICES 104527 1 2885 133157 136042 162080 162080 2261665 1629560 632105 632105 632105 GRANT REFUNDS 900099 15549 15549 15549 945776 15549 0 794185 212973 212973 61367 61367 20000 16000 4000 18568 8062 7605 2901 1087 238 679 170 10467 7430 2397 640 1619 354 1012 253 3398 3398 28521 28521 104527 104527 25270 22390 2880 2471 1753 202 516 11804 11804 14557 14034 523 5828 5828 1379 1379 675 286 351 38 RESEARCH & INFORMATION 899 121 125 653 525410 367417 149942 8051 138764 225817 407504 403178 18805 60997 9396 9396 0 0 9074310 10737802 368468 414164 10007851 11841958 1335 761 0 6013 1335 6774 X 9210421 10977780 796095 857404 10006516 11835184 10007851 11841958 X 420366 1362606 45696 X 0 1 X 1 0 X 152985 308221 83569 57870 136042 738687 152985 308221 83569 57870 136042 738687 66451 672236 133102 135729 137909 162465 162080 731285 15549 15549 1485521 0.45250 0.46740 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: GRANT REFUNDS - 2019 AMOUNT: $ 15,549. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 9074310 2033864 370372 10737802 9615924 -166192 375422 9074310 8490686 1425720 300482 9615924 8053691 737413 300418 8490686 8058586 295238 300133 8053691 1.00000 0.00000 0.00000 1 0 9396 9396 0 0 DUE TO AFFILIATES 6013 6013 X 2234002 1362606 -58831 1303775 930227 15549 15549 945776 405334 -15549 -15549 420883 104527 104527 525410 PART V, LINE 4: THE ORGANIZATION'S QUASI-ENDOWMENT FUNDS FUND THE VARIOUS ACTIVITIES OF ARDF. THIS INCLUDES FUNDING RESEARCH PROJECTS THAT DEVELOP NON-ANIMAL ALTERNATIVES TO TRADITIONAL ANIMAL EXPERIMENTS AND SPONSORSHIP OF SCIENTIFIC MEETINGS PROMOTING ALTERNATIVES. PART X, LINE 2: MANAGEMENT BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX PROVISIONS TAKEN, AND AS SUCH, THE FOUNDATION DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE FINANCIAL STATEMENTS. THE FOUNDATION'S FEDERAL RETURN OF ORGANIZATION EXEMPT FROM INCOME TAX (FORM 990) FOR 2019, 2018, AND 2017 IS SUBJECT TO EXAMINATION BY THE INTERNAL REVENUE SERVICE, GENERALLY FOR THREE YEARS AFTER THE DATE THE RETURN WAS FILED. PART XI, LINE 2D - OTHER ADJUSTMENTS: UNREALIZED GAIN (LOSS) ON BENEFICIAL INTEREST IN PERPETUAL TRUST 45,696. INVESTMENT FEES -104,527. PART XI, LINE 4B - OTHER ADJUSTMENTS: REVENUE NET WITH EXPENSES 15,549. PART XII, LINE 2D - OTHER ADJUSTMENTS: REVENUE NET WITH EXPENSES -15,549. PART XII, LINE 4B - OTHER ADJUSTMENTS: INVESTMENT FEES 104,527. 1 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 PROGRAM SERVICES RESEARCH GRANTS 61367 0 0 0 0 0 0 61367 0 61367 THE NETHERLANDS TO SUPPORT THE FCS[FETAL CALF SERUM]-FREE DATABASE AND ADVANCING SERUM-FREE MEDIA FOR IN VITRO CELL CULTURES 10000 THE NETHERLANDS SPONSORSHIP OF 11TH WORLD CONGRESS ON ALTERNATIVES AND ANIMAL USE IN THE LIFE SCIENCES 11387 ITALY DRS. FORTUNA AND SOLER RESEARCH GRANT 39980 2 1 0 0 0 0 0 0 PART I, LINE 2: PROGRESS REPORTS FOR RESEARCH GRANTS ARE REQUIRED AFTER 8 MONTHS AND FINAL REPORT IS DUE WHEN THE SUPPORTED PROGRAM IS COMPLETE. ANY UNUSED FUNDS MUST BE RETURNED OR USED FOR APPROVED PURPOSES ONLY. PART III ACCOUNTING METHOD: 1 UNIVERSITY OF FLORIDA 207 GRINTER HALL PO BOX 115500 GAINESVILLE FL 326115500 596002052 501(C)(3) 39831 DRS. MELISSA JONES AND MARIOLA EDELMANN RESEARCH GRANT SOCIETY FOR IN VITRO BIOLOGY 514 DANIELS STREET SUITE 411 RALEIGH NC 27605 560844407 501(C)(3) 5000 SUPPORT OF THE SOCIETY FOR IN VITRO BIOLOGY 2019 MEETING UNIVERSITY OF BUFFALO SCHOOL OF PHARMACY AND PHARMACEUTICAL SCIENCES 166 PHARMACY BUILDING BUFFALO NY 14214 141368361 501(C)(3) 39600 DRS. RAYMOND CHA AND BRIAN TSUJI RESEARCH GRANT ILLINOIS INSTITUTE OF TECHNOLOGY 10 W 35TH STREET SUITE 7D7-1 CHICAGO IL 60616 362170136 501(C)(3) 39996 DR. ABHINAV BHUSHAN RESEARCH GRANT WAKE FOREST UNIVERSITY HEALTH SCIENCES MEDICAL CENTER BOULEVARD WINSTONSALEM NC 27157 560532138 501(C)(3) 40000 DR. COLIN BISHOP RESEARCH GRANT UNIVERSITY OF VIRGINIA PO BOX 400195 CHARLOTTESVILLE VA 229044195 546001796 501(C)(3) 40000 DRS. LI JIN AND XUDONG LI RESEARCH GRANT 6 PART I, LINE 2: PROGRESS REPORTS FOR RESEARCH GRANTS ARE REQUIRED AFTER 8 MONTHS AND A FINAL REPORT IS DUE WHEN THE SUPPORTED PROGRAM IS COMPLETE. ANY UNUSED FUNDS MUST BE RETURNED OR USED FOR APPROVED PURPOSES ONLY. FORM 990, PART IX AND SCHEDULE I GRANT MONIES UNDER $5,000 AND REFUNDS OF UNUSED FUNDS CAUSED THE AMOUNTS REPORTED ON SCHEDULE I TO BE LESS THAN THE AMOUNT REPORTED ON PART IX, LINE 1. FORM 990, PART VI, SECTION B, LINE 11B THE PRESIDENT, TREASURER, AND BOARD OF DIRECTORS REVIEW THE FORM 990 BEFORE IT IS FILED. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION FOLLOWS THE POLICIES OF ITS AFFILIATE, AMERICAN ANTI-VIVISECTION SOCIETY (AAVS), WITH WHICH IT SHARES ITS BOARD OF MANAGERS. THE BOARD OF MANAGERS MONITORS AND ENFORCES COMPLIANCE WITH THE CONFLICT OF INTEREST POLICIES (AS DETERMINED BY AAVS). ANNUAL DISCLOSURE FORMS ARE COLLECTED FROM EACH BOARD MEMBER AND REVIEWED BY THE PRESIDENT WHO ENSURES THAT MEMBERS RECUSE THEMSELVES FROM VOTING ON ANY MATTERS IN WHICH THEY MAY HAVE A DUAL INTEREST. THE BOARD OF MANAGERS, EXCLUDING THE PRESIDENT, ENSURES THAT THE PRESIDENT RECUSES HERSELF IN CASE OF A POTENTIAL CONFLICT OF INTEREST. THE CONFLICT OF INTEREST POLICY EXPLICITLY DEEMS FAMILY AND BUSINESS RELATIONSHIPS TO HAVE POTENTIAL FOR CONFLICTS AND REQUESTS DETAILED INFORMATION ON ANY SUCH RELATIONSHIPS AS PART OF THE ANNUAL CONFLICT OF INTEREST POLICY PROCESS. FORM 990, PART VI, SECTION B, LINE 15A THE ORGANIZATION'S COMPENSATION POLICIES ARE DICTATED BY ITS AFFILIATE, AMERICAN ANTI-VIVISECTION SOCIETY (AAVS) WITH WHOM IT SHARES A BOARD OF MANAGERS. THE FULL BOARD OF MANAGERS ANNUALLY DETERMINES COMPENSATION OF THE PRESIDENT BY COMPARING WITH COMPENSATION OF EQUIVALENT POSITIONS USING PUBLICLY AVAILABLE DATA. NOTE THE PRESIDENT'S SALARY IS DETERMINED BY AAVS BUT IS REPORTED ON BOTH RETURNS. DECISIONS ARE RECORDED IN BOARD MINUTES AND MATERIALS. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS, THE CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. FORM 990, PART XI, LINE 9: UNREALIZED GAIN (LOSS) ON BENEFICIAL INTEREST IN PERPETUAL TRUST 45,696. FORM 990, PART V, LINE 2A AND PART IX SALARIES REFLECTED ON THE STATEMENT OF FUNCTIONAL EXPENSES ARE ALLOCATIONS OF SALARIES AS A PORTION OF MANAGEMENT EXPENSES THAT THE ORGANIZATION PAYS TO ITS AFFILIATE, THE AMERICAN ANTI-VIVISECTION SOCIETY. NOTE THAT THE ONE EMPLOYEE, SUE LEARY, IS PAID BY A COMMON PAYMASTER, THE ORGANIZATION'S AFFILIATE AMERICAN ANTI-VIVISECTION SOCIETY. THERE IS NO W-3 REPORTED FOR THIS ENTITY; ALL FILING REQUIREMENTS ARE MET THROUGH THE AFFILIATE AS MENTIONED. AMERICAN ANTI-VIVISECTION SOCIETY 801 OLD YORK NOBLE PLAZA JENKINTOWN PA 19046 230341990 EDUCATE THE PUBLIC ON PROBLEMS OF ANIMAL EXPERIMENTATION PA 501(C)(3) LINE 7 NONE 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0 0